BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 15484967)

  • 1. Thick prescriptions: toward an interpretation of pharmaceutical sales practices.
    Oldani MJ
    Med Anthropol Q; 2004 Sep; 18(3):325-56. PubMed ID: 15484967
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Marketing pharmaceutical products to physicians. Sales reps influence physicians' impressions of the industry.
    Creyer EH; Hrsistodoulakis I
    Mark Health Serv; 1998; 18(2):34-8. PubMed ID: 10180333
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmaceutical marketing strategies' influence on physicians' prescribing pattern in Lebanon: ethics, gifts, and samples.
    Khazzaka M
    BMC Health Serv Res; 2019 Jan; 19(1):80. PubMed ID: 30700295
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Qualitative insights into promotion of pharmaceutical products in Bangladesh: how ethical are the practices?
    Mohiuddin M; Rashid SF; Shuvro MI; Nahar N; Ahmed SM
    BMC Med Ethics; 2015 Dec; 16(1):80. PubMed ID: 26625723
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmaceutical promotion: don't throw the baby out with the bathwater.
    Dubois RW
    Health Aff (Millwood); 2003; Suppl Web Exclusives():W3-96-103. PubMed ID: 14527238
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Analysis of Pharmaceutical Industry Marketing of Stimulants, 2014 Through 2018.
    Hadland SE; Cerdá M; Earlywine JJ; Krieger MS; Anderson TS; Marshall BDL
    JAMA Pediatr; 2020 Apr; 174(4):385-387. PubMed ID: 31961384
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmaceutical sales representatives and the doctor/patient relationship.
    Wall LL; Brown D
    Obstet Gynecol; 2002 Sep; 100(3):594-9. PubMed ID: 12220784
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Marketing drugs: debating the real cost. Concern about close ties between doctors and pharmaceutical firms are prompting new financial disclosure laws and education efforts.
    Brand R
    State Legis; 2008 Sep; 34(8):26-9. PubMed ID: 18754159
    [No Abstract]   [Full Text] [Related]  

  • 9. Interactions between physicians and the pharmaceutical industry generally and sales representatives specifically and their association with physicians' attitudes and prescribing habits: a systematic review.
    Fickweiler F; Fickweiler W; Urbach E
    BMJ Open; 2017 Sep; 7(9):e016408. PubMed ID: 28963287
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Proposed guidelines for housestaff interaction with pharmaceutical companies.
    Forrest DM; Ruedy J
    Ann R Coll Physicians Surg Can; 1993 Oct; 26(5):291-3. PubMed ID: 15362243
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of physician payment disclosure laws on prescribing.
    Pham-Kanter G; Alexander GC; Nair K
    Arch Intern Med; 2012 May; 172(10):819-21. PubMed ID: 22636826
    [No Abstract]   [Full Text] [Related]  

  • 12. Pharmaceutical marketing research and the prescribing physician.
    Greene JA
    Ann Intern Med; 2007 May; 146(10):742-8. PubMed ID: 17502635
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Study affirms PhRMA's influence on physicians.
    Miller JD
    J Natl Cancer Inst; 2007 Aug; 99(15):1148-50. PubMed ID: 17652272
    [No Abstract]   [Full Text] [Related]  

  • 14. Physicians' decision process for drug prescription and the impact of pharmaceutical marketing mix instruments.
    Campo K; De Staebel O; Gijsbrechts E; van Waterschoot W
    Health Mark Q; 2005; 22(4):73-107. PubMed ID: 16597584
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reconciling a "pleasant exchange" with evidence of information bias: A three-country study on pharmaceutical sales visits in primary care.
    Reynolds E; Guénette L; Lexchin J; Cassels A; Wilkes MS; Durrieu G; Beaulieu MD; Mintzes B
    Health Policy; 2018 Mar; 122(3):250-255. PubMed ID: 29395543
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Doctors' Interactions with Pharmaceutical Sales Representatives: Modelling Doctors Prescription Behaviour.
    Faisal A; Ahmad MS; Thurasamy R; Ahmed R
    Community Ment Health J; 2020 Apr; 56(3):456-463. PubMed ID: 31728716
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Doctors who take company cash are more likely to prescribe brand name drugs, analysis finds.
    McCarthy M
    BMJ; 2016 Mar; 352():i1645. PubMed ID: 27000964
    [No Abstract]   [Full Text] [Related]  

  • 18. Interactions between emergency medicine programs and the pharmaceutical industry.
    Keim SM; Mays MZ; Grant D
    Acad Emerg Med; 2004 Jan; 11(1):19-26. PubMed ID: 14709424
    [TBL] [Abstract][Full Text] [Related]  

  • 19. "But doctors do it...": nurses' views of gifts and information from the pharmaceutical industry.
    Jutel A; Menkes DB
    Ann Pharmacother; 2009 Jun; 43(6):1057-63. PubMed ID: 19470854
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Academic Detailing: "Marketing" the Best Evidence to Clinicians.
    Avorn J
    JAMA; 2017 Jan; 317(4):361-362. PubMed ID: 28118458
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.